Risk of bleeding with 2 doses of dabigatran compared with warfarin in older and younger patients with atrial fibrillation: an analysis of the randomized evaluation of long-term anticoagulant therapy (RE-LY) trial
scientific article published on 16 May 2011
Author/s
author: John W. Eikelboom, Lars Wallentin, Hans-Christoph Diener, Salim Yusuf, Jonas Oldgren, Stefan H Hohnloser, Muredach P. Reilly, A Marco Alings, Jeanne Varrone, Maria Grazia Franzosi, Sean Yang, Mike Ezekowitz, Scott Kaatz
Work details
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.